Buddlejasaponin IVb is primarily studied for its potential pharmacological applications. It exhibits significant anti-inflammatory properties, making it a candidate for developing treatments for inflammatory diseases. Additionally, it has shown promise in cancer research due to its ability to inhibit the growth of certain cancer cells. Its antioxidant effects are also being explored for potential use in protecting cells from oxidative stress-related damage. Further research is ongoing to fully understand its therapeutic potential and mechanisms of action.